Shandong Weigao Group Medical Polymer Stock price
Compare with Peer Group
Is Shandong Weigao Group Medical Polymer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.
Key metrics
Shandong Weigao Group Medical Polymer Stock Analysis
Analyst Opinions
15 Analysts have issued a Shandong Weigao Group Medical Polymer forecast:
Analyst Opinions
15 Analysts have issued a Shandong Weigao Group Medical Polymer forecast:
Don't miss a Thing! We will send you all news about Shandong Weigao Group Medical Polymer directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 12,719 full-time employees. The company went IPO on 2004-02-27. The firm operates six segments. Medical Device Products segment engaged in the production and sale of clinical care, medical testing, anesthesia and surgical related products and other consumables. Orthopaedic Products segment engaged in the production and sale of orthopaedic products, including tissue repair product line. Interventional Products segment engages in production and sale of tumor and blood vessel interventional instruments. Pharma Packaging Products segment includes production and sale of pre-filled syringes and flushing syringes. Blood Management Products segment includes production and sale of blood collection, irradiation, storage, separation and sterilization products. Others segment includes finance lease and factoring business.
| Head office | China |
| CEO | Mr. Cong |
| Employees | 13,307 |
| Website | www.weigaoholding.com |


